10-Q

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 27, 2021

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 0-5109

MICROPAC INDUSTRIES, INC.

Delaware	75-1225149
(State of Incorporation)	(IRS Employer Identification No.)

905 E. Walnut, Garland, Texas	75040
(Address of Principal Executive Office)	(Zip Code)

Registrant’s Telephone Number, including Area Code: (972) 272-3571

Securities Registered Pursuant to Section 12(g) of the Act: common stock, par value $0.10.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of large accelerated filer,” accelerated filer,” smaller reporting company,” and emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer   [  ]	Emerging growth company     [  ]
Accelerated filer [  ] Non-accelerated filer [  ]	Smaller reporting company [X]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [ ]

On April 13, 2021 there were 2,578,315 shares of Common Stock, $0.10 par value, outstanding.

1 

MICROPAC INDUSTRIES, INC.

FORM 10-Q

February 27, 2021

INDEX

PART I - FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 4 - CONTROLS AND PROCEDURES

PART II - OTHER INFORMATION

ITEM 1 - LEGAL PROCEEDINGS

ITEM 1A - RISK FACTORS

ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES

ITEM 4 - MINE SAFETY DISCLOSURE

ITEM 5 - OTHER INFORMATION

ITEM 6 - EXHIBITS

2 

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

MICROPAC INDUSTRIES, INC.

CONDENSED BALANCE SHEETS

(Dollars in thousands)

	2/27/2021			11/30/2020
		(Unaudited)
CURRENT ASSETS
Cash and cash equivalents	$	13,330		$	14,619
Receivables, net of allowance for doubtful accounts of        $0 at February 27, 2021 and November 30, 2020		1,567			2,639
Income tax receivable		—			200
Contract assets		723			512
Inventories:
Raw materials and supplies		5,962			5,792
Work-in process		3,910			3,345
Total inventories		9,872			9,137
Prepaid expenses and other assets		349			515
Prepaid income tax		267			—
Total current assets		26,108			27,622
PROPERTY, PLANT AND EQUIPMENT, at cost:
Land		1,518			1,518
Buildings		498			498
Facility improvements		1,109			1,109
Furniture and fixtures		1,018			1,015
Construction in process equipment		1,542			1,044
Machinery and equipment		9,312			9,169
Total property, plant, and equipment		14,997			14,353
Less accumulated depreciation		(10,481	)		(10,418	)
Net property, plant, and equipment		4,516			3,935
Operating lease right to use asset		105			117
Deferred income taxes, net		27			27
Total assets	$	30,756		$	31,701
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$	786		$	843
Accrued compensation		687			981
Deferred revenue		132			111
Property taxes		78			129
Other accrued liabilities		98			53
Total current liabilities		1,781			2,117
Operating lease liabilities		67			117
Total liabilities		1,848			2,234
Commitments and contingencies
SHAREHOLDERS’ EQUITY
Common stock, $.10 par value, authorized 10,000,000 shares, 3,078,315 issued and 2,578,315 outstanding at February 27, 2021 and November 30, 2020		308			308
Additional paid-in-capital		885			885
Treasury stock, 500,000 shares, at cost		(1,250	)		(1,250	)
Retained earnings		28,965			29,524
Total shareholders’ equity		28,908			29,467
Total liabilities and shareholders’ equity	$	30,756		$	31,701

See accompanying notes to financial statements.

3 

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Dollars in thousands except share data)

(Unaudited)

	Three months ended
		02/27/2021			02/29/2020
NET SALES	$	4,050		$	5,957
COST AND EXPENSES:
Cost of goods sold		(2,690	)		(3,325	)
Research and development		(344	)		(478	)
Selling, general and administrative expenses		(1,390	)		(1,376	)
Total cost and expenses		(4,424	)		(5,179	)
OPERATING INCOME (LOSS)		(374	)		778
Other income, net		24			26
INCOME (LOSS) BEFORE TAXES		(350	)		804
(Provision) benefit for taxes		49			(112	)
NET INCOME (LOSS)	$	(301	)	$	692
NET INCOME (LOSS) PER SHARE, BASIC AND DILUTED	$	(0.12	)	$	0.27
DIVIDENDS PER SHARE	$	0.10		$	0.10
WEIGHTED AVERAGE OF SHARES, basic and diluted		2,578,315			2,578,315

See accompanying notes to financial statements.

4 

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

	Three months ended
		02/27/2021			02/29/2020
CASH FLOWS FROM OPERATING ACTIVITES:
Net income (loss)	$	(301	)	$	692
Adjustments to reconcile net income (loss) to
net cash used in operating activities:
Depreciation		98			98
Amortization		12			12
Change in right of use of asset		12			12
Changes in certain current assets and liabilities
Accounts receivable		1,072			(93	)
Contract assets		(211	)		(345	)
Inventories		(735	)		(735	)
Prepaid expense and other current assets		166			131
Prepaid income taxes		(71	)		0
Deferred revenue		21			(148	)
Accounts payable		(57	)		(14	)
Income taxes		—			105
Lease liabilities		(12	)		(12	)
Accrued compensation		(292	)		(622	)
Other accrued liabilities		(44	)		(67	)
Net cash used in operating activities		(354	)		(998	)
CASH FLOWS FROM INVESTING ACTIVITIES:
Sale of short term investments		—			2,090
Purchase of short term investments		—			(1	)
Additions to property, plant and equipment		(677	)		(17	)
Net cash provided by (used in) investing activities		(677	)		2,072
CASH FLOWS FROM FINANCING ACTIVITIES
Cash dividend		(258	)		(258	)
Net cash used in financing activities		(258	)		(258	)
Net change in cash and cash equivalents		(1,289	)		816
Cash and cash equivalents at beginning of period		14,619			13,890
Cash and cash equivalents at end of period	$	13,330		$	14,706
Supplemental Cash Flow Disclosure:
Cash paid for income taxes	$	243		$	7

See accompanying notes to financial statements.

5 

MICROPAC INDUSTRIES, INC.

STATEMENTS OF SHAREHOLDERS’ EQUITY

FOR THE QUARTERS ENDED FEBRUARY 27, 2021 AND FEBRUARY 29, 2020

(Dollars in thousands)

(Unaudited)

	Common		Additional		Treasury			Retained
	Stock		paid-in-capital		Stock			Earnings			Total
BALANCE, November 30, 2019	$	308	$	885	$	(1,250	)	$	28,310		$	28,253
Dividend		—		—		—			(258	)		(258	)
Net loss		—		—		—			692			692
BALANCE, February 29, 2020	$	308	$	885	$	(1,250	)	$	28,744		$	28,687
	Common		Additional		Treasury			Retained
	Stock		paid-in-capital		Stock			Earnings			Total
BALANCE, November 30, 2020	$	308	$	885	$	(1,250	)	$	29,524		$	29,467
Dividend		—		—		—			(258	)		(258	)
Net income		—		—		—			(301	)		(301	)
BALANCE, February 27, 2021	$	308	$	885	$	(1,250	)	$	28,965		$	28,908

See accompanying notes to financial statements.

6 

MICROPAC INDUSTRIES, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

Note 1 BASIS OF PRESENTATION

Business Description

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200^o C) products.

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2008 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier, and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

The Company’s core technology are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

The business of the Company was started in 1963 as a sole proprietorship. On March 3, 1969, the Company was incorporated under the name of “Micropac Industries, Inc.” in the state of Delaware. The stock was publicly held by 438 shareholders on February 27, 2021.

In the opinion of management, the unaudited financial statements include all adjustments (consisting of only normal, recurring adjustments) necessary to present fairly the financial position as of February 27, 2021, the results of operations and cash flows for the three months ended February 27, 2021 and February 29, 2020. Unaudited financial statements are prepared on a basis substantially consistent with those audited for the year ended November 30, 2020. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (GAAP) have been condensed or omitted pursuant to the rules and regulations promulgated by the Securities and Exchange Commission. The Company’s fiscal year ends on the last day of November. The quarterly results end on the last Saturday of the quarter.

It is suggested that these financial statements be read in conjunction with the November 30, 2020 Form 10-K filed with the SEC, including the audited financial statements and the accompanying notes thereto.

Note 2 SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

The Company's revenue on the majority of its customer contracts are recognized at a point in time, generally upon shipment of products.

To achieve that core principle, the Company applies the following steps:

7 

1. Identify the contract(s) with a customer.

The Company designs, manufactures and distributes various types of microelectronic circuits, optoelectronics, and sensors and displays. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200^o C) products.

The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

2. Identify the performance obligations in the contract.

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

3. Determine the transaction price.

The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.

4. Allocate the transaction price to the performance obligations in the contract.

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

5. Recognize revenue when (or as) the Company satisfies a performance obligation.

This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each delivery upon shipment and recognizes revenues at the fixed price for each distinct product delivered when transfer of control has occurred, which is generally upon shipment.

For certain contracts under which the Company produces products with no alternative use and for which the Company has an enforceable right to payment during the production cycle, the Company recognizes revenue for the cost incurred of work in process plus a margin at the end of each period and records a contract asset (unbilled receivable). The majority of these products are shipped weekly and monthly to the customers and the contracts require us to manage and limit the level of work in process to meet the scheduled delivery dates.

In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed and performance obligations are determined and we recognize revenue at the point in time in which each performance obligation is fully satisfied.

Disaggregation of Revenue

The following table summarizes the Company’s net sales by product line.

	Feb. 27, 2021		Feb. 29, 2020
Microelectronics	$	723	$	1,828
Optoelectronics		1,379		1,574
Sensors and Displays		1,948		2,555
	$	4,050	$	5,957
Timing of revenue recognition
Recognized at a point in time	$	3,327	$	5,093
Recognized over time		723		864
Total Revenue	$	4,050	$	5,957

The following table summarizes the Company’s net sales by major market.

8 

2021 First Quarter Sales by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	1,423	$	219	$	550	$	148	$	2,340
Domestic Distribution		1,027		364		0		119		1,510
International		63		127		—		10		200
	$	2,513	$	710	$	550	$	277	$	4,050
2020 First Quarter Sales by Major Market
		Military		Space		Medical		Commercial		Total
Domestic Direct	$	1,142	$	685	$	757	$	395	$	2,979
Domestic Distribution		2,492		—		5		110		2,607
International		168		171		—		32		371
	$	3,802	$	856	$	762	$	537	$	5,957

Receivables, net, Contract Assets and Contract Liabilities

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (deferred revenue) on the Consolidated Balance Sheet. 

Receivables, net, contract assets and contract liabilities were as follows:

	February 27, 2021		November 30, 2020
Receivables	$	1,567	$	2,639
Contract assets	$	723	$	512
Deferred revenue	$	132	$	111

There was no revenue recognized in 2021 that was included in the deferred revenue liability balance at the beginning of the year.

Contract costs

The Company does not have material incremental costs to obtain a contract in the form of sales commissions or bonuses. The Company incurs other immaterial costs to obtain and fulfill a contract; however, the Company has elected the practical expedient under ASC 340-40-24-4 to recognize all incremental costs to obtain a contract as an expense when incurred if the amortization period is one year or less.

Leases

In the first quarter of 2020, the Company entered into a three (3) year lease extension on the property that has been leased on a year to year basis. As a result, we recognized $ 165,000 for operating lease liabilities and right-of-use assets in accordance with ASC 842. The Company had an operating lease expense of $12,000 for the first three months of 2021 and 2020. The Company used an estimated incremental borrowing rate of 3.25% representative of the rate of interest that the company would have to pay to borrow on the Company’s line of credit. The remaining lease term is three years.

The undiscounted future minimum lease payments consist of the following at:

	2/27/2021
2021		40,000
2022		55,000
2023		14,000
Total lease payments		109,000
Interest		4,000
Present value of lease liabilities	$	105,000

9 

Short-Term Investments

The Company had no short-term investments at February 27, 2021 or November 30, 2020. Short-term investments consist of certificates of deposits with maturities greater than 90 days. These investments are reported at historical cost, which approximates fair value. All highly liquid investments with maturities of 90 days or less are classified as cash equivalents.

Inventories

Inventories are stated at lower of cost or net realizable value and include material, labor and manufacturing overhead. All inventories are valued using the FIFO (first-in, first-out) method of inventory valuation. The Company determines the need to write inventory down to the lower of cost or net realizable value via an analysis based on the usage of inventory over a three year period and projected usage based on current backlog.

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method the Company records deferred income taxes for the temporary differences between the financial reporting basis and the tax basis of assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. The resulting deferred tax liabilities and assets are adjusted to reflect changes in tax law or rates in the period that includes the enactment date.

The Company records a liability for an unrecognized tax benefit for a tax position that is not “more-likely-than-not” to be sustained.  The Company did not record any liability for uncertain tax positions as of February 27, 2021 or November 30, 2020.

Property, Plant, and Equipment

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:

Buildings....................................................................................................................................................15

Facility improvements......................................................................................................................... 8-15

Machinery and equipment................................................................................................................. 5-10

Furniture and fixtures ...........................................................................................................................5-8

The Company assesses long-lived assets for impairment in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) ASC 360-10-35, Property, Plant and Equipment – Subsequent Measurement. When events or circumstances indicate that an asset may be impaired, an assessment is performed. The estimated future undiscounted cash flows associated with the asset are compared to the asset’s net book value to determine if a write down to market value less cost to sell is required.

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

Research and Development Costs

Costs for the design and development of new products are expensed as incurred.

Basic and Diluted Earnings Per Share

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common shares. For the three months ended February 27, 2021 and February 29, 2020, the Company had no dilutive potential common stock instruments.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

10 

Note 3 NEW ACCOUNTING PRONOUNCEMENTS

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. The ASU requires the use of an “expected loss” model for instruments measured at amortized cost, in which companies will be required to estimate the lifetime expected credit loss and record an allowance to offset the amortized cost basis, resulting in a net presentation of the amount expected to be collected on the financial asset. The new guidance is effective for fiscal years beginning after December 15, 2022 for Smaller Reporting Companies, including interim periods within those fiscal years and requires a modified-retrospective approach to adoption. The Company believes that adopting ASU 2016-13 will have no material impact on the financial statements and related disclosures.

Note 4 FAIR VALUE MEASUREMENT

The Company had no financial assets or liabilities measured at fair value on a recurring basis as of February 27, 2021 or November 30, 2020.  The fair value of financial instruments such as cash and cash equivalents, short term investments, accounts receivable, and accounts payable approximate their carrying amount based on the short maturity of these instruments.  There were no nonfinancial assets measured at fair value on a nonrecurring basis at February 27, 2021 or November 30, 2020.

Note 5 COMMITMENTS

The Company obtained a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas that the Company has purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement with Frost Bank (“Frost”), (acting as lender). The Construction Loan Agreement provides for a construction loan, in amounts not to exceed a total principal balance of $16,160,000 with an interest rate of (3.40%) per annum.

On March 26, 2021, the Company renewed the Revolving Loan Agreement with Frost through the “Sixth Amendment to Loan Agreement.” (Attached as Exhibit 10.2 hereto). The Revolving Loan Agreement provides for revolving credit loans, in amounts not to exceed a total principal balance of $6,000,000 with a rate equal to prime rate. The Revolving Loan Agreement was originally entered into on January 23, 2013, between the “Company” as borrower and Frost as lender.  

Construction Loans.  Subject to the terms of the Loan Agreement, Frost will lend to the Company an aggregate amount not to exceed $16,160,000.00.

Principal and interest shall be due and payable monthly in an amounts determined by Lender required to fully amortize the outstanding principal balance of this Note over a period of twenty-five (25) years, payable on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2023, and continuing regularly thereafter until March 26, 2031, when the entire amount hereof, principal and accrued interest then remaining unpaid, shall be then due and payable; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

The interest rate of (3.40%) per annum including an Interest-Only Period. Interest only shall be due and payable monthly as it accrues on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2021, and continuing regularly and monthly thereafter until March 26, 2023; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

The loan shall be secured by a “Deed of Trust, Security Agreement – Financing Statement” covering the 9.2 acre tract in Garland, Texas and the improvements made on it.

Revolving Credit Loans.  Subject to the terms of the, Loan Agreement, Frost will lend to the Company, on a revolving basis, amounts not to exceed a total principal balance of $6,000,000.00, minus amounts available and amounts previously disbursed under outstanding Frost letters of credit. Subject to certain terms and conditions, the Company may borrow, repay and reborrow under the Loan Agreement.

The interest on the outstanding and unpaid principal balance shall be computed at a per annum rate equal to the lesser of (a) a rate equal to the Prime Rate per annum; provided, however, in no event shall the resulting rate be less than three and one-quarter percent (3.25%).

11 

Note 6 EARNINGS PER COMMON SHARE

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common shares. For the three months ended February 27, 2021 and February 29, 2020, the Company had no dilutive potential common stock instruments.

Note 7 SHAREHOLDERS’ EQUITY

On December 8, 2020, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 6, 2021. The dividend was paid to shareholders on February 12, 2021.

On December 10, 2019, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 8, 2020. The dividend was paid to shareholders on February 14, 2020.

[The remainder of this page intentionally left blank.]

12 

MICROPAC INDUSTRIES, INC.

(Unaudited)

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Business

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200^o C) products.

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2008 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier, and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

The Company’s core technology are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We base our estimates on historical experience and on various other assumptions and factors that are believed to be reasonable under the circumstances. Note 2 to the Financial Statements in the Quarterly Report Form 10-Q for the quarter ended February 27, 2021, describes the significant accounting policies and methods used in the preparation of the Financial Statements. liabilities. Actual results could differ from these estimates.

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company’s revenue on the majority of its customer contracts are recognized at a point in time, generally upon shipment of products. The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates. Specifically, the determination of whether revenues related to our revenue contracts should be recognized over time or at a point in time, as these determinations impact the timing and amount of our reported revenues and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to receive payment, as well as the progress of the job order to completion in order to determine the amount of consideration earned for contractual revenue recognized over time.

The allowance for doubtful accounts is based on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. If there is a deterioration of a major customer’s credit worthiness or actual defaults are higher than our historical experience, our estimates of the recoverability of amounts due us could be adversely affected.

Inventory purchases and commitments are based upon future demand. If there is a sudden and significant decrease in demand for our products or there is a higher risk of inventory obsolescence because of changing customer requirements, we may be required to increase our inventory allowances and our gross margin could be adversely affected.

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. If we were to determine we would not be able to realize all or part of the deferred tax asset in the future, an adjustment to the deferred tax asset would be necessary which would reduce our net income for that period.

13 

Depreciable and useful lives estimated for property and equipment are based on initial expectations of the period of time these assets will provide benefit. Changes in circumstances related to a change in our business or other factors could result in these assets becoming impaired, which could adversely affect the value of these assets.

Results of Operations

	Three months ended
		2/27/2021		02/29/2020
NET SALES		100.0	%	100.0	%
COST AND EXPENSES:
Cost of Goods Sold		66.4	%	55.8	%
Research and development		8.5	%	8.0	%
Selling, general & administrative expenses		34.3	%	23.1	%
Total cost and expenses		109.2	%	86.9	%
OPERATING INCOME (LOSS)		(9.2	)%	13.1	%
Other income, net		0.6	%	0.4	%
INCOME (LOSS) BEFORE TAXES		(8.6	)%	13.5	%
(Provision) benefit for taxes		1.2	%	(1.9	)%
INCOME (LOSS)		(7.4	)%	11.6	%

Sales for the first quarter ended February 27, 2021 totaled $4,050,000. Sales for the first quarter decreased 32% or $1,907,000 below sales for the first quarter of 2020. The decrease in sales were across all product lines with the majority of the decrease in standard solid state relays associated with timing of new orders and shipments for the standard solid state relay products. The company is expecting an additional $4,000,000 in new orders in the second quarter for standard solid state relay products. In addition, the Company was shut down for a week in February due to the Texas winter storm resulting in a week of lost production and associated shipments.

Two customers accounted for 17% and 12% of the Company’s sales for the first quarter of 2021 and two customers accounted for 27% and 11% of the Company’s sales for the first quarter of 2020. Two of the customers are distributors that sell to multiple customers.

Cost of goods sold for the first quarter of 2021 and 2020 totaled 66.4% and 55.8% of net sales, respectively. Cost of sales decreased $635,000 or 32% for the first quarter of 2021, as compared to the first quarter of 2020, resulting in lower margins due to under absorbed overhead.

Research and development cost decreased $134,000 for the first quarter of 2021 compared to the same period of 2020. The research and development expenditures were associated with the continued development of power management products, sensor products and process automation improvements.

Selling, general and administrative expenses for the first quarter of 2021 totaled 34.3% of net sales, compared to 23.1% for the same period in 2020. Selling, general and administrative expenses increased $14,000 in the first quarter of 2021 as compared to 2020.

Provisions for taxes decreased $161,000 for the first quarter of 2021 compared to the same period in 2020. The estimated effective tax rate was 14% for the first quarter of 2021 and the first quarter of 2020.

The Company had a net loss in the first quarter of 2021 of $301,000 compared to a net income of $692,000 in the first quarter of 2020 associated with the lower sales compared to 2020 resulting in the first quarter loss due to under absorbed overhead and selling, general and administrative expense.

Liquidity and Capital Resources

The Company will use a combination of cash and a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas the Company purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement

14 

with Frost Bank (“Frost”), (acting as lender). The Construction Loan Agreement provides for a construction loan as discussed in Note 5 to the condensed financial statements.

In addition, the Company continues on-going investigations for the use of cumulative cash for business expansion and improvements, such as operational improvements and new product expansion.

Cash and cash equivalents totaled $13,330,000 as of February 27, 2021 compared to $14,619,000 on November 30, 2020, an decrease of $1,289,000. The decrease in cash and cash equivalents is attributable to $354,000 cash used in operations, a payment of a cash dividend of $258,000, and $677,000 invested in equipment and design effort on the new facility.

In addition to cash on hand, the Company also has the ability to borrow under a loan agreement as discussed in Note 5 to the condensed financial statements.

The Company has no significant off-balance sheet arrangements.

Outlook

New orders for the first quarter of 2021 totaled $5,549,000 compared to $5,597,000 for the comparable period of 2020. Backlog totaled $31,586,000 on February 27, 2021 compared to $21,889,000 as of February 29, 2020 and $29,727,000 on November 30, 2020. The majority of the increase in backlog is associated with domestic military products. Approximately $21,000,000 of the current backlog is expected to ship during the remainder of 2021.

2021 Current Backlog by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	14,769	$	2,975	$	2,803	$	2,284	$	22,831
Domestic Distribution		6,941		614		0		451	$	8,006
International		104		527		—		118	$	749
	$	21,814	$	4,116	$	2,803	$	2,853	$	31,586

2021 Current Backlog by Product Line
Microelectronics	$	6,720
Optoelectronics		10,118
Sensors and Displays		14,748
	$	31,586

The Company cannot assure that the results of operations for the interim period presented are indicative of total results for the entire year due to fluctuations in customer delivery schedules, or other factors over which the Company has no control.

Impact of COVID-19 on our Business

The spread of the COVID-19 virus during the first half of 2020 has caused an economic downturn on a global scale, as well as significant volatility in the financial markets. In March 2020 the World Health Organization declared the spread of the COVID-19 virus a pandemic. The Company continues to monitor our supply chain and orders from customers for COVID-19 pandemic related changes. In this time of uncertainty as a result of the COVID-19 pandemic, we are continuing to serve our customers while taking precautions to provide a safe work environment for our employees and customers. We have been staggering some shifts and otherwise adjusting work schedules to maximize our capacity while adhering to recommended precautions such as social distancing. We have established and implemented a work from home provision where possible. We may have to take further actions that we determine are in the best interests of our employees or as required by federal, state, or local authorities.

We experienced multiple confirmed case of COVID-19 during 2021 and 2020, which caused us to shut down our Garland facility for a few days to thoroughly clean the facility and address employee concerns. Production in the Garland facility has been impacted, although we are not able to quantify the impact at this time. Our maquiladora contractor in Mexico was shut down during April and May of 2020 but reopened as of mid-June at limited capacity due to local restrictions in that area.

The impact of the COVID-19 pandemic continues to unfold. The extent of the pandemic’s effect on our operational and financial performance will depend in large part on future developments, which cannot be predicted with

15 

confidence at this time. Future developments include the duration, scope and severity of the pandemic, the actions taken to contain or mitigate its impact, the impact on governmental programs and budgets, the development of treatments or vaccines, and the resumption of widespread economic activity. Due to the inherent uncertainty of the unprecedented and rapidly evolving situation, we are unable to predict with any confidence the likely impact of the COVID-19 pandemic on our future operations.

Cautionary Statement

This Form 10-Q contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially. Investors are warned that forward-looking statements involve risks and unknown factors including, but not limited to: our expectations regarding the potential impacts on our operations of the COVID-19 pandemic; our expectations regarding the potential impacts on our supply chain and on our customers of the COVID-19 pandemic; overall changes in governmental spending for military and space programs; customer cancellation or rescheduling of orders, problems affecting delivery of vendor-supplied raw materials and components, unanticipated manufacturing problems and availability of direct labor resources.

The Company does not intend to update the forward-looking statements contained herein, except as may be required by law.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable

ITEM 4. CONTROLS AND PROCEDURES

(a) Evaluation of disclosure controls and procedures.

The Chief Executive Officer and Chief Financial Officer of the Company evaluated the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15) as of February 27, 2021 and, based on this evaluation, concluded that the Company’s disclosure controls and procedures are functioning in an effective manner to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms.

(b) Changes in internal controls.

There has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting during the three month period ended February 27, 2021.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The Company is not involved in any material current or pending legal proceedings.

ITEM 1A RISK FACTORS

Information about risk factors for the three months ended February 27, 2021 does not differ materially from that set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended November 30, 2020.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None

ITEM 4. MINE SAFETY DISCLOSURE

Not Applicable

16 

ITEM 5. OTHER INFORMATION

On March 5, 2021, Micropac Industries, Inc. held its Annual Meeting. Of the 2,578,315 shares of common stock outstanding and entitled to vote, 2,215,150 shares, or 85.9%, were represented at the meeting in person or by proxy, and therefore a quorum was present. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:

Proposal One: To elect six directors to serve until the next annual meeting of stockholders or until their respective successors are elected and qualified;

Nominee	Votes For	Votes Withheld
Mark King	2,207,497	7,653
Heinz-Werner Hempel	2,207,497	7,653
Christine B. Dittrich	2,207,497	7,653
Gerald Tobey	2,207,497	7,653
Donald Robinson	2,207,497	7,653
Shaunna Black	2,207,497	7,653

ITEM 6. EXHIBITS

(a)        Exhibits

31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.
32.2	Certification of Chief Accounting Officer pursuant to 18 U. S. C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

17 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.

MICROPAC INDUSTRIES, INC.

April 13, 2021	/s/ Mark King
Date	Mark King
	Chief Executive Officer

April 13, 2021	/s/ Patrick Cefalu
Date	Patrick Cefalu
	Chief Financial Officer

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark King, certify that:

1. I have reviewed this quarterly report of Micropac Industries, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: April 13, 2021	/s/ Mark King
	Mark King
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Patrick S. Cefalu, certify that:

1. I have reviewed this quarterly report of Micropac Industries, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: April 13, 2021	/s/ Patrick Cefalu
	Patrick S. Cefalu
	Executive Vice President
	and Chief Financial Officer
	(Principal Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Micropac Industries, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

1. The Quarterly Report on Form 10-Q for the period ended February 27, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: April 13, 2021	/s/ Mark King
	Mark King
	Chief Executive Officer
	(Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Micropac Industries, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

1. The Quarterly Report on Form 10-Q for the period ended February 27, 2021 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: April 13, 2021	/s/ Patrick Cefalu
	Patrick S. Cefalu
	Executive Vice President
	and Chief Financial Officer
	(Principal Accounting Officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	3 Months Ended
	Feb. 27, 2021	Apr. 13, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Feb. 27, 2021
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--11-30
Entity File Number	000-05109
Entity Registrant Name	MICROPAC INDUSTRIES INC
Entity Central Index Key	0000065759
Entity Incorporation, State or Country Code	DE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,578,315

XML

Balance Sheets (Unaudited) - USD ($) $ in Thousands	Feb. 27, 2021	Nov. 30, 2020
CURRENT ASSETS
Cash and cash equivalents	$ 13,330	$ 14,619
Receivables, net of allowance for doubtful accounts of $0 at February 27, 2021 and November 30, 2020	1,567	2,639
Income tax receivable		200
Contract assets	723	512
Inventories:
Raw materials and supplies	5,962	5,792
Work-in process	3,910	3,345
Total inventories	9,872	9,137
Prepaid expenses and other assets	349	515
Prepaid income tax	267
Total current assets	26,108	27,622
PROPERTY, PLANT AND EQUIPMENT, at cost:
Land	1,518	1,518
Buildings	498	498
Facility improvements	1,109	1,109
Furniture and fixtures	1,018	1,015
Construction in process equipment	1,542	1,044
Machinery and equipment	9,312	9,169
Total property, plant, and equipment	14,997	14,353
Less accumulated depreciation	(10,481)	(10,418)
Net property, plant, and equipment	4,516	3,935
Operating lease right to use asset	105	117
Deferred income taxes, net	27	27
Total assets	30,756	31,701
CURRENT LIABILITIES:
Accounts payable	786	843
Accrued compensation	687	981
Deferred revenue	132	111
Property taxes	78	129
Other accrued liabilities	98	53
Total current liabilities	1,781	2,117
Operating lease liabilities	67	117
Total liabilities	1,848	2,234
SHAREHOLDERS’ EQUITY
Common stock, $.10 par value, authorized 10,000,000 shares, 3,078,315 issued and 2,578,315 outstanding at February 27, 2021 and November 30, 2020	308	308
Additional paid-in-capital	885	885
Treasury stock, 500,000 shares, at cost	(1,250)	(1,250)
Retained earnings	28,965	29,524
Total shareholders’ equity	28,908	29,467
Total liabilities and shareholders’ equity	$ 30,756	$ 31,701

XML

Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Feb. 27, 2021	Nov. 30, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 0	$ 0
Common Stock, par value	$ .1	$ .1
Common Stock, shares authorized	10,000,000	10,000,000
Common Stock, shares issued	3,078,315	3,078,315
Common Stock, shares outstanding	2,578,315	2,578,315
Treasury stock, shares	500,000	500,000

XML

Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Feb. 27, 2021	Feb. 29, 2020
Income Statement [Abstract]
NET SALES	$ 4,050	$ 5,957
COST AND EXPENSES:
Cost of goods sold	(2,690)	(3,325)
Research and development	(344)	(478)
Selling, general and administrative expenses	(1,390)	(1,376)
Total cost and expenses	(4,424)	(5,179)
OPERATING INCOME (LOSS)	(374)	778
Other income, net	24	26
INCOME (LOSS) BEFORE TAXES	(350)	804
(Provision) benefit for taxes	49	(112)
NET INCOME (LOSS)	$ (301)	$ 692
NET INCOME (LOSS) PER SHARE, BASIC AND DILUTED	$ (0.12)	$ 0.27
DIVIDENDS PER SHARE	$ 0.10	$ 0.10
WEIGHTED AVERAGE OF SHARES, basic and diluted	2,578,315	2,578,315

XML

Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Feb. 27, 2021	Feb. 29, 2020
CASH FLOWS FROM OPERATING ACTIVITES:
Net income (loss)	$ (301)	$ 692
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	98	98
Amortization	12	12
Change in right of use of asset	12	12
Changes in certain current assets and liabilities
Accounts receivable	1,072	(93)
Contract assets	(211)	(345)
Inventories	(735)	(735)
Prepaid expense and other current assets	166	131
Prepaid income taxes	(71)	0
Deferred revenue	21	(148)
Accounts payable	(57)	(14)
Income taxes		105
Lease liabilities	(12)	(12)
Accrued compensation	(292)	(622)
Other accrued liabilities	(44)	(67)
Net cash used in operating activities	(354)	(998)
CASH FLOWS FROM INVESTING ACTIVITIES:
Sale of short term investments		2,090
Purchase of short term investments		(1)
Additions to property, plant and equipment	(677)	(17)
Net cash provided by (used in) investing activities	(677)	2,072
CASH FLOWS FROM FINANCING ACTIVITIES
Cash dividend	(258)	(258)
Net cash used in financing activities	(258)	(258)
Net change in cash and cash equivalents	(1,289)	816
Cash and cash equivalents at beginning of period	14,619	13,890
Cash and cash equivalents at end of period	13,330	14,706
Supplemental Cash Flow Disclosure:
Cash paid for income taxes	$ 243	$ 7

XML

Shareholders Equity (Unaudited) - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Treasury Stock	Retained Earnings / Accumulated Deficit	Total
Beginning Balance at Nov. 30, 2019	$ 308	$ 885	$ (1,250)	$ 28,310	$ 28,253
Dividend				(258)	(258)
Net Income				692	692
Ending Balance at Feb. 29, 2020	308	885	(1,250)	28,744	28,687
Beginning Balance at Nov. 30, 2020	308	885	(1,250)	29,524	29,467
Dividend				(258)	(258)
Net Income				(301)	(301)
Ending Balance at Feb. 27, 2021	$ 308	$ 885	$ (1,250)	$ 28,965	$ 28,908

XML

1. BASIS OF PRESENTATION

3 Months Ended

Feb. 27, 2021

Accounting Policies [Abstract]

BASIS OF PRESENTATION

Note 1 BASIS OF PRESENTATION

Business Description

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200^o C) products.

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2008 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier, and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

The Company’s core technology are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

The business of the Company was started in 1963 as a sole proprietorship. On March 3, 1969, the Company was incorporated under the name of “Micropac Industries, Inc.” in the state of Delaware. The stock was publicly held by 438 shareholders on February 27, 2021.

In the opinion of management, the unaudited financial statements include all adjustments (consisting of only normal, recurring adjustments) necessary to present fairly the financial position as of February 27, 2021, the results of operations and cash flows for the three months ended February 27, 2021 and February 29, 2020. Unaudited financial statements are prepared on a basis substantially consistent with those audited for the year ended November 30, 2020. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (GAAP) have been condensed or omitted pursuant to the rules and regulations promulgated by the Securities and Exchange Commission. The Company’s fiscal year ends on the last day of November. The quarterly results end on the last Saturday of the quarter.

It is suggested that these financial statements be read in conjunction with the November 30, 2020 Form 10-K filed with the SEC, including the audited financial statements and the accompanying notes thereto.

XML

2. SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Feb. 27, 2021

Accounting Policies [Abstract]

SIGNIFICANT ACCOUNTING POLICIES

Note 2 SIGNIFICANT ACCOUNTING POLICIES

Revenue Recognition

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

The Company's revenue on the majority of its customer contracts are recognized at a point in time, generally upon shipment of products.

To achieve that core principle, the Company applies the following steps:

1. Identify the contract(s) with a customer.

The Company designs, manufactures and distributes various types of microelectronic circuits, optoelectronics, and sensors and displays. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200^o C) products.

The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

2. Identify the performance obligations in the contract.

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

3. Determine the transaction price.

The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.

4. Allocate the transaction price to the performance obligations in the contract.

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

5. Recognize revenue when (or as) the Company satisfies a performance obligation.

This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each delivery upon shipment and recognizes revenues at the fixed price for each distinct product delivered when transfer of control has occurred, which is generally upon shipment.

For certain contracts under which the Company produces products with no alternative use and for which the Company has an enforceable right to payment during the production cycle, the Company recognizes revenue for the cost incurred of work in process plus a margin at the end of each period and records a contract asset (unbilled receivable). The majority of these products are shipped weekly and monthly to the customers and the contracts require us to manage and limit the level of work in process to meet the scheduled delivery dates.

In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed and performance obligations are determined and we recognize revenue at the point in time in which each performance obligation is fully satisfied.

Disaggregation of Revenue

The following table summarizes the Company’s net sales by product line.

	Feb. 27, 2021		Feb. 29, 2020
Microelectronics	$	723	$	1,828
Optoelectronics		1,379		1,574
Sensors and Displays		1,948		2,555
	$	4,050	$	5,957
Timing of revenue recognition
Recognized at a point in time	$	3,327	$	5,093
Recognized over time		723		864
Total Revenue	$	4,050	$	5,957

The following table summarizes the Company’s net sales by major market.

2021 First Quarter Sales by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	1,423	$	219	$	550	$	148	$	2,340
Domestic Distribution		1,027		364		0		119		1,510
International		63		127		—		10		200
	$	2,513	$	710	$	550	$	277	$	4,050
2020 First Quarter Sales by Major Market
		Military		Space		Medical		Commercial		Total
Domestic Direct	$	1,142	$	685	$	757	$	395	$	2,979
Domestic Distribution		2,492		—		5		110		2,607
International		168		171		—		32		371
	$	3,802	$	856	$	762	$	537	$	5,957

Receivables, net, Contract Assets and Contract Liabilities

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (deferred revenue) on the Consolidated Balance Sheet. 

Receivables, net, contract assets and contract liabilities were as follows:

	February 27, 2021		November 30, 2020
Receivables	$	1,567	$	2,639
Contract assets	$	723	$	512
Deferred revenue	$	132	$	111

There was no revenue recognized in 2021 that was included in the deferred revenue liability balance at the beginning of the fiscal year.

Contract costs

The Company does not have material incremental costs to obtain a contract in the form of sales commissions or bonuses. The Company incurs other immaterial costs to obtain and fulfill a contract; however, the Company has elected the practical expedient under ASC 340-40-24-4 to recognize all incremental costs to obtain a contract as an expense when incurred if the amortization period is one year or less.

Leases

In the first quarter of 2020, the Company entered into a three (3) year lease extension on the property that has been leased on a year to year basis. As a result, we recognized $ 165,000 for operating lease liabilities and right-of-use assets in accordance with ASC 842. The Company had an operating lease expense of $12,000 for the first three months of 2021 and 2020. The Company used an estimated incremental borrowing rate of 3.25% representative of the rate of interest that the company would have to pay to borrow on the Company’s line of credit. The remaining lease term is three years.

The undiscounted future minimum lease payments consist of the following at:

	2/27/2021
2021		40,000
2022		55,000
2023		14,000
Total lease payments		109,000
Interest		4,000
Present value of lease liabilities	$	105,000

Short-Term Investments

The Company had no short-term investments at February 27, 2021 or November 30, 2020. Short-term investments consist of certificates of deposits with maturities greater than 90 days. These investments are reported at historical cost, which approximates fair value. All highly liquid investments with maturities of 90 days or less are classified as cash equivalents.

Inventories

Inventories are stated at lower of cost or net realizable value and include material, labor and manufacturing overhead. All inventories are valued using the FIFO (first-in, first-out) method of inventory valuation. The Company determines the need to write inventory down to the lower of cost or net realizable value via an analysis based on the usage of inventory over a three year period and projected usage based on current backlog.

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method the Company records deferred income taxes for the temporary differences between the financial reporting basis and the tax basis of assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. The resulting deferred tax liabilities and assets are adjusted to reflect changes in tax law or rates in the period that includes the enactment date.

The Company records a liability for an unrecognized tax benefit for a tax position that is not “more-likely-than-not” to be sustained.  The Company did not record any liability for uncertain tax positions as of February 27, 2021 or November 30, 2020.

Property, Plant, and Equipment

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:

Buildings....................................................................................................................................................15

Facility improvements......................................................................................................................... 8-15

Machinery and equipment................................................................................................................. 5-10

Furniture and fixtures ...........................................................................................................................5-8

The Company assesses long-lived assets for impairment in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) ASC 360-10-35, Property, Plant and Equipment – Subsequent Measurement. When events or circumstances indicate that an asset may be impaired, an assessment is performed. The estimated future undiscounted cash flows associated with the asset are compared to the asset’s net book value to determine if a write down to market value less cost to sell is required.

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

Research and Development Costs

Costs for the design and development of new products are expensed as incurred.

Basic and Diluted Earnings Per Share

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common shares. For the three months ended February 27, 2021 and February 29, 2020, the Company had no dilutive potential common stock instruments.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

XML

3. NEW ACCOUNTING PRONOUNCEMENTS

3 Months Ended

Feb. 27, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

NEW ACCOUNTING PRONOUNCEMENTS

Note 3 NEW ACCOUNTING PRONOUNCEMENTS

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. The ASU requires the use of an “expected loss” model for instruments measured at amortized cost, in which companies will be required to estimate the lifetime expected credit loss and record an allowance to offset the amortized cost basis, resulting in a net presentation of the amount expected to be collected on the financial asset. The new guidance is effective for fiscal years beginning after December 15, 2022 for Smaller Reporting Companies, including interim periods within those fiscal years and requires a modified-retrospective approach to adoption. The Company believes that adopting ASU 2016-13 will have no material impact on the financial statements and related disclosures.

XML

4. FAIR VALUE MEASUREMENT

3 Months Ended

Feb. 27, 2021

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENT

Note 4 FAIR VALUE MEASUREMENT

The Company had no financial assets or liabilities measured at fair value on a recurring basis as of February 27, 2021 or November 30, 2020.  The fair value of financial instruments such as cash and cash equivalents, short term investments, accounts receivable, and accounts payable approximate their carrying amount based on the short maturity of these instruments.  There were no nonfinancial assets measured at fair value on a nonrecurring basis at February 27, 2021 or November 30, 2020.

XML

5. COMMITMENTS

3 Months Ended

Feb. 27, 2021

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS

Note 5 COMMITMENTS

The Company obtained a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas that the Company has purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement with Frost Bank (“Frost”), (acting as lender). The Construction Loan Agreement provides for a construction loan, in amounts not to exceed a total principal balance of $16,160,000 with an interest rate of (3.40%) per annum.

On March 26, 2021, the Company renewed the Revolving Loan Agreement with Frost through the “Sixth Amendment to Loan Agreement.” (Attached as Exhibit 10.2 hereto). The Revolving Loan Agreement provides for revolving credit loans, in amounts not to exceed a total principal balance of $6,000,000 with a rate equal to prime rate. The Revolving Loan Agreement was originally entered into on January 23, 2013, between the “Company” as borrower and Frost as lender.  

Construction Loans.  Subject to the terms of the Loan Agreement, Frost will lend to the Company an aggregate amount not to exceed $16,160,000.00.

Principal and interest shall be due and payable monthly in an amounts determined by Lender required to fully amortize the outstanding principal balance of this Note over a period of twenty-five (25) years, payable on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2023, and continuing regularly thereafter until March 26, 2031, when the entire amount hereof, principal and accrued interest then remaining unpaid, shall be then due and payable; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

The interest rate of (3.40%) per annum including an Interest-Only Period. Interest only shall be due and payable monthly as it accrues on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2021, and continuing regularly and monthly thereafter until March 26, 2023; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

The loan shall be secured by a “Deed of Trust, Security Agreement – Financing Statement” covering the 9.2 acre tract in Garland, Texas and the improvements made on it.

Revolving Credit Loans.  Subject to the terms of the, Loan Agreement, Frost will lend to the Company, on a revolving basis, amounts not to exceed a total principal balance of $6,000,000.00, minus amounts available and amounts previously disbursed under outstanding Frost letters of credit. Subject to certain terms and conditions, the Company may borrow, repay and reborrow under the Loan Agreement.

The interest on the outstanding and unpaid principal balance shall be computed at a per annum rate equal to the lesser of (a) a rate equal to the Prime Rate per annum; provided, however, in no event shall the resulting rate be less than three and one-quarter percent (3.25%).

XML

6. EARNINGS PER COMMON SHARE

3 Months Ended

Feb. 27, 2021

Earnings Per Share [Abstract]

EARNINGS PER COMMON SHARE

Note 6 EARNINGS PER COMMON SHARE

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common shares. For the three months ended February 27, 2021 and February 29, 2020, the Company had no dilutive potential common stock instruments.

XML

7. SHAREHOLDERS' EQUITY

3 Months Ended

Feb. 27, 2021

Dividends, Common Stock [Abstract]

SHAREHOLDERS' EQUITY

Note 7 SHAREHOLDERS’ EQUITY

On December 10, 2019, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 8, 2020. The dividend was paid to shareholders on February 14, 2020.

On December 8, 2020, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 6, 2021. The dividend was paid to shareholders on February 12, 2021.

XML

2. SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Feb. 27, 2021

Accounting Policies [Abstract]

Revenue Recognition

Revenue Recognition

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

The Company's revenue on the majority of its customer contracts are recognized at a point in time, generally upon shipment of products.

To achieve that core principle, the Company applies the following steps:

1. Identify the contract(s) with a customer.

The Company designs, manufactures and distributes various types of microelectronic circuits, optoelectronics, and sensors and displays. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200^o C) products.

The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

2. Identify the performance obligations in the contract.

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

3. Determine the transaction price.

The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.

4. Allocate the transaction price to the performance obligations in the contract.

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

5. Recognize revenue when (or as) the Company satisfies a performance obligation.

This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each delivery upon shipment and recognizes revenues at the fixed price for each distinct product delivered when transfer of control has occurred, which is generally upon shipment.

For certain contracts under which the Company produces products with no alternative use and for which the Company has an enforceable right to payment during the production cycle, the Company recognizes revenue for the cost incurred of work in process plus a margin at the end of each period and records a contract asset (unbilled receivable). The majority of these products are shipped weekly and monthly to the customers and the contracts require us to manage and limit the level of work in process to meet the scheduled delivery dates.

In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed and performance obligations are determined and we recognize revenue at the point in time in which each performance obligation is fully satisfied.

Disaggregation of Revenue

Disaggregation of Revenue

The following table summarizes the Company’s net sales by product line.

	Feb. 27, 2021		Feb. 29, 2020
Microelectronics	$	723	$	1,828
Optoelectronics		1,379		1,574
Sensors and Displays		1,948		2,555
	$	4,050	$	5,957
Timing of revenue recognition
Recognized at a point in time	$	3,327	$	5,093
Recognized over time		723		864
Total Revenue	$	4,050	$	5,957

The following table summarizes the Company’s net sales by major market.

2021 First Quarter Sales by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	1,423	$	219	$	550	$	148	$	2,340
Domestic Distribution		1,027		364		0		119		1,510
International		63		127		—		10		200
	$	2,513	$	710	$	550	$	277	$	4,050
2020 First Quarter Sales by Major Market
		Military		Space		Medical		Commercial		Total
Domestic Direct	$	1,142	$	685	$	757	$	395	$	2,979
Domestic Distribution		2,492		—		5		110		2,607
International		168		171		—		32		371
	$	3,802	$	856	$	762	$	537	$	5,957

Receivables, net, Contract Assets and Contract Liabilities

Receivables, net, Contract Assets and Contract Liabilities

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (deferred revenue) on the Consolidated Balance Sheet. 

Receivables, net, contract assets and contract liabilities were as follows:

	February 27, 2021		November 30, 2020
Receivables	$	1,567	$	2,639
Contract assets	$	723	$	512
Deferred revenue	$	132	$	111

There was no revenue recognized in 2021 that was included in the deferred revenue liability balance at the beginning of the fiscal year.

Contract costs

Contract costs

The Company does not have material incremental costs to obtain a contract in the form of sales commissions or bonuses. The Company incurs other immaterial costs to obtain and fulfill a contract; however, the Company has elected the practical expedient under ASC 340-40-24-4 to recognize all incremental costs to obtain a contract as an expense when incurred if the amortization period is one year or less.

Leases

Leases

In the first quarter of 2020, the Company entered into a three (3) year lease extension on the property that has been leased on a year to year basis. As a result, we recognized $ 165,000 for operating lease liabilities and right-of-use assets in accordance with ASC 842. The Company had an operating lease expense of $12,000 for the first three months of 2021 and 2020. The Company used an estimated incremental borrowing rate of 3.25% representative of the rate of interest that the company would have to pay to borrow on the Company’s line of credit. The remaining lease term is three years.

The undiscounted future minimum lease payments consist of the following at:

	2/27/2021
2021		40,000
2022		55,000
2023		14,000
Total lease payments		109,000
Interest		4,000
Present value of lease liabilities	$	105,000

Short-Term Investments

Short-Term Investments

The Company had no short-term investments at February 27, 2021 or November 30, 2020. Short-term investments consist of certificates of deposits with maturities greater than 90 days. These investments are reported at historical cost, which approximates fair value. All highly liquid investments with maturities of 90 days or less are classified as cash equivalents.

Inventories

Inventories

Inventories are stated at lower of cost or net realizable value and include material, labor and manufacturing overhead. All inventories are valued using the FIFO (first-in, first-out) method of inventory valuation. The Company determines the need to write inventory down to the lower of cost or net realizable value via an analysis based on the usage of inventory over a three year period and projected usage based on current backlog.

Income Taxes

Income Taxes

The Company accounts for income taxes using the asset and liability method. Under this method the Company records deferred income taxes for the temporary differences between the financial reporting basis and the tax basis of assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. The resulting deferred tax liabilities and assets are adjusted to reflect changes in tax law or rates in the period that includes the enactment date.

The Company records a liability for an unrecognized tax benefit for a tax position that is not “more-likely-than-not” to be sustained.  The Company did not record any liability for uncertain tax positions as of February 27, 2021 or November 30, 2020.

Property, Plant, and Equipment

Property, Plant, and Equipment

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:

Buildings....................................................................................................................................................15

Facility improvements......................................................................................................................... 8-15

Machinery and equipment................................................................................................................. 5-10

Furniture and fixtures ...........................................................................................................................5-8

The Company assesses long-lived assets for impairment in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) ASC 360-10-35, Property, Plant and Equipment – Subsequent Measurement. When events or circumstances indicate that an asset may be impaired, an assessment is performed. The estimated future undiscounted cash flows associated with the asset are compared to the asset’s net book value to determine if a write down to market value less cost to sell is required.

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

Research and Development Costs

Research and Development Costs

Costs for the design and development of new products are expensed as incurred.

Basic and Diluted Earnings Per Share

Basic and Diluted Earnings Per Share

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common shares. For the three months ended February 27, 2021 and February 29, 2020, the Company had no dilutive potential common stock instruments.

Use of Earnings

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

XML

2. SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Feb. 27, 2021

Accounting Policies [Abstract]

Net sales by product line

	Feb. 27, 2021		Feb. 29, 2020
Microelectronics	$	723	$	1,828
Optoelectronics		1,379		1,574
Sensors and Displays		1,948		2,555
	$	4,050	$	5,957
Timing of revenue recognition
Recognized at a point in time	$	3,327	$	5,093
Recognized over time		723		864
Total Revenue	$	4,050	$	5,957

Net sales by major market

2021 First Quarter Sales by Major Market
	Military		Space		Medical		Commercial		Total
Domestic Direct	$	1,423	$	219	$	550	$	148	$	2,340
Domestic Distribution		1,027		364		0		119		1,510
International		63		127		—		10		200
	$	2,513	$	710	$	550	$	277	$	4,050
2020 First Quarter Sales by Major Market
		Military		Space		Medical		Commercial		Total
Domestic Direct	$	1,142	$	685	$	757	$	395	$	2,979
Domestic Distribution		2,492		—		5		110		2,607
International		168		171		—		32		371
	$	3,802	$	856	$	762	$	537	$	5,957

Receivables, net, contract assets and contract liabilities

	February 27, 2021		November 30, 2020
Receivables	$	1,567	$	2,639
Contract assets	$	723	$	512
Deferred revenue	$	132	$	111

Undiscounted future minimum leases

	2/27/2021
2021		40,000
2022		55,000
2023		14,000
Total lease payments		109,000
Interest		4,000
Present value of lease liabilities	$	105,000

Property and equipment schedule of useful lives

Buildings....................................................................................................................................................15

Facility improvements......................................................................................................................... 8-15

Machinery and equipment................................................................................................................. 5-10

Furniture and fixtures ...........................................................................................................................5-8

XML

2. SIGNIFICANT ACCOUNTING POLICIES (Details - Net Sales by Product Line) - USD ($) $ in Thousands	Feb. 27, 2021	Feb. 29, 2020
Accounting Policies [Abstract]
Microcircuits	$ 723	$ 1,828
Optoelectronics	1,379	1,574
Sensors and Displays	1,948	2,555
Total Sales	4,050	5,957
Transferred at a point in time	3,327	5,093
Transferred over time	723	864
Total Revenue	$ 4,050	$ 5,957

XML

2. SIGNIFICANT ACCOUNTING POLICIES (Details - Distributions) - USD ($) $ in Thousands	3 Months Ended
	Feb. 27, 2021	Feb. 29, 2020
Military [Member]
Domestic Direct	$ 1,423	$ 1,142
Domestic Distribution	1,027	2,492
International	63	168
Total net distributions	2,513	3,802
Space [Member]
Domestic Direct	219	685
Domestic Distribution	364
International	127	171
Total net distributions	710	856
Medical [Member]
Domestic Direct	550	757
Domestic Distribution	0	5
International
Total net distributions	550	762
Commercial [Member]
Domestic Direct	148	395
Domestic Distribution	119	110
International	10	32
Total net distributions	277	537
Total [Member]
Domestic Direct	2,340	2,979
Domestic Distribution	1,510	2,607
International	200	371
Total net distributions	$ 4,050	$ 5,957

XML

2. SIGNIFICANT ACCOUNTING POLICIES (Details - Receivables, net, contract assets and contract liabilities) - USD ($) $ in Thousands	Feb. 27, 2021	Nov. 30, 2020
Accounting Policies [Abstract]
Receivables	$ 1,567	$ 2,639
Contract assets	723	512
Deferred revenues	$ 132	$ 111

XML

2. SIGNIFICANT ACCOUNTING POLICIES (Details - Undiscounted Future Minimum Leases) $ in Thousands	Nov. 29, 2020 USD ($)
Accounting Policies [Abstract]
Minimum lease payment 2021	$ 40,000
Minimum lease payment 2022	55,000
Minimum lease payment 2023	14,000
Total lease payments	109,000
Interest	4,000
Present value of lease liabilities	$ 105,000

XML

2. SIGNIFICANT ACCOUNTING POLICIES (Details - Property Lives)	3 Months Ended
	Feb. 27, 2021
Buildings [Member] | Minimum [Member]
Estimated useful lives	15 years
Buildings [Member] | Maximum [Member]
Estimated useful lives	15 years
Facility Improvements [Member] | Minimum [Member]
Estimated useful lives	8 years
Facility Improvements [Member] | Maximum [Member]
Estimated useful lives	15 years
Machinery and Equipment [Member] | Minimum [Member]
Estimated useful lives	5 years
Machinery and Equipment [Member] | Maximum [Member]
Estimated useful lives	10 years
Furniture and Fixtures [Member] | Minimum [Member]
Estimated useful lives	5 years
Furniture and Fixtures [Member] | Maximum [Member]
Estimated useful lives	8 years

XML

2. SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) $ in Thousands	3 Months Ended
	Feb. 27, 2021 USD ($)
Accounting Policies [Abstract]
Lease expense	$ 12,000
Estimated incremental borrowing rate	3.25%

XML

5. COMMITMENTS (Details Narrative) $ in Thousands	Mar. 26, 2021 USD ($)
Construction Loan Agreement [Member]
Credit line maximum	$ 16,160,000
Maximum interest rate	3.40%
Revolving Loan Agreement [Member]
Credit line maximum	$ 6,000,000
Maximum interest rate	3.25%

XML

7. SHAREHOLDERS' EQUITY (Details Narrative) - $ / shares	3 Months Ended
	Feb. 27, 2021	Feb. 29, 2020
Dividend per share	$ 0.10	$ 0.10
Dividend 1 [Member]
Date of declaration		Dec. 10, 2019
Dividend per share		$ .1
Record date		Jan. 08, 2020
Dividend paid date		Feb. 14, 2020
Dividend 2 [Member]
Date of declaration	Dec. 08, 2020
Dividend per share	$ .1
Record date	Jan. 06, 2021
Dividend paid date	Feb. 12, 2021